Skip Navigation LinksHome > January 2011 - Volume 19 - Issue 1 > Community-Acquired Multi-Drug Resistant Escherichia coli in...
Infectious Diseases in Clinical Practice:
doi: 10.1097/IPC.0b013e3181e928bc
Case Reports

Community-Acquired Multi-Drug Resistant Escherichia coli in a Patient Presenting With Pyelonephritis

Dinani, Amreen MD*; Urban, Carl PhD*†‡; Colon-Urban, Rita PhD§; Wehbeh, Wehbeh MD*†

Collapse Box

Abstract

TEM and SHV extended-spectrum β-lactamases (ESBLs) used to be the dominant ESBLs in the 1990s, but more recently, the emergence of CTX-M enzymes have been increasingly recognized worldwide. Gram-negative rods harboring these β-lactamases represent a significant challenge to both clinicians and microbiologists due to the increasing number of reported cases of bacteria-producing ESBLs from the community. We highlight the case of a CTX-M-15-producing Escherichia coli urinary tract isolate causing infection in a patient from the community with no significant risk factors for acquiring E. coli harboring blaCTX-M.

© 2011 Lippincott Williams & Wilkins, Inc.

Article Tools

Share

Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.